NCT00217152View on ClinicalTrials.gov

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

PHASE4TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Kidney TransplantationDelayed Graft Function
Interventions
DRUG

CellCept

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00217152 - A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors | Biotech Hunter | Biotech Hunter